Deal or Case news
NautaDutilh has assisted Partners Group, the global private markets firm, together with Ropes & Gray on its acquisition of Pharmathen, a leading European pharmaceutical company, from the international investment firm BC Partners. The transaction values Pharmathen at an enterprise value of around EUR 1.6 billion.

Founded in 1969, Pharmathen is a leading contract development and manufacturing organization specialized in advanced drug delivery technologies for complex generic pharmaceutical products.

The NautaDutilh team was led by corporate partner Rebecca Runa Pinto - Noome and further consisted of Jos Somers (Corporate M&A), Greet Wilkenhuysen, Caroline Notté (Corporate Luxembourg), Elizabeth van Schilfgaarde, Marc Orval, (Finance), Aira Scheijvens, Ruben Martens (Corporate Notarial), Nina Kielman (Tax), Jolize Lautenbach (Public law), Jeroen Boelens (Pharma/IP), Daniël Kuiper (Employment), Josée Weydert (Finance), David Al Mari (Corporate), Vasiliki Gerou (Finance) and Sarah Sorensen (Corporate).

Partners Group is a leading global private markets firm. Partners Group's private equity team has invested more than USD 5 billion in Health & Life companies on behalf of its clients since inception.

Related articles

Cookie notification

This functionality uses third-party cookies. Change your cookie preferences to view this content or view more information.
These cookies ensure that the website works properly. These cookies cannot be disabled.
These cookies can be placed by third parties, such as YouTube or Vimeo.
By deactivating categories, it is possible that related functionalities within the website may no longer work properly. It is always possible to change your preferences at a later time. View more information.